Jun 2026 (Q2 FY26) — Jul 31, 2026
Ingersoll Rand Q2 FY26 — Strong Execution, Raised Revenue Guidance, and Robust M&A
Read the full callIngersoll Rand (IR) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Ingersoll Rand earnings: last reported Fri, 31 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 2,049 | +8.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 18.6 | +14.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 257 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Guidance
What management said, and what became of it
9 of 10 judged targets kept · 14 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Middle East long-cycle order delay recovery / FY26 revenue-EBITDA impact | full recovery during 2026 of the ~$40 million delayed orders; no impact to full-year 2026 revenue or adjusted EBITDA | Mar 2026 | Organic order growth was impacted by the timing of several loan cycle blower and vacuum projects in Europe as well as the continued impact on the Middle East, where specific project activity remains delayed rather than canceled. | Delayed |
| Full-year adjusted EBITDA | $2.13 billion to $2.19 billion | Dec 2025 | We're maintaining our adjusted EBITDA guidance range of $2.13 billion to $2.19 billion. | On Track |
1 of Ingersoll Rand Inc.'s 24 targets was missed. See which ones, and which are quietly gone. The 2 above are the free sample; 22 more targets are in the full ledger.
Claimed
- Organic order growth of 2% in Q2 FY26.
- Organic revenue growth of 4% in Q2 FY26.
- Adjusted EPS grew 7% year-over-year to $0.86 in Q2 FY26.
- Free cash flow increased 28% year-over-year to $269 million in Q2 FY26.
- PST Adjusted EBITDA margin expanded 200 bps year-over-year to 31.5% in Q2 FY26.
- Double-digit organic order growth observed in the first four weeks of July.
Qualified
- Adjusted EBITDA margin declined 160 bps year-over-year to 25.4% in Q2 FY26, driven by inflationary pressures (primarily China), growth investments, and higher corporate costs.
- Book-to-bill finished at 1.0 turns in Q2 FY26, slightly lower than typical, reflecting delayed timing of several large project orders.
- ITS margin performance was impacted by challenges offsetting inflationary impacts with price, primarily in China.
Price
$77.75 −0.04% · −$0.03
Performance +0.7% 1Y
1Y: $77.22 on 17 Oct 2025 → $77.75. High $98.76 (17 Feb 2026), low $68.54 (19 May 2026).
- Previous close
- $77.78
- 52-week range
- $68.54 – $98.76
- One year
- −0.92%
Overview
- Symbol
- IR
- Sector
- Industrials
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
9 of 10 judged targets kept · 14 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Middle East long-cycle order delay recovery / FY26 revenue-EBITDA impact | full recovery during 2026 of the ~$40 million delayed orders; no impact to full-year 2026 revenue or adjusted EBITDA | Mar 2026 | Organic order growth was impacted by the timing of several loan cycle blower and vacuum projects in Europe as well as the continued impact on the Middle East, where specific project activity remains delayed rather than canceled. | Delayed |
| Full-year adjusted EBITDA | $2.13 billion to $2.19 billion | Dec 2025 | We're maintaining our adjusted EBITDA guidance range of $2.13 billion to $2.19 billion. | On Track |
Claimed
- Organic order growth of 2% in Q2 FY26.
- Organic revenue growth of 4% in Q2 FY26.
- Adjusted EPS grew 7% year-over-year to $0.86 in Q2 FY26.
- Free cash flow increased 28% year-over-year to $269 million in Q2 FY26.
- PST Adjusted EBITDA margin expanded 200 bps year-over-year to 31.5% in Q2 FY26.
- Double-digit organic order growth observed in the first four weeks of July.
Qualified
- Adjusted EBITDA margin declined 160 bps year-over-year to 25.4% in Q2 FY26, driven by inflationary pressures (primarily China), growth investments, and higher corporate costs.
- Book-to-bill finished at 1.0 turns in Q2 FY26, slightly lower than typical, reflecting delayed timing of several large project orders.
- ITS margin performance was impacted by challenges offsetting inflationary impacts with price, primarily in China.
The full ledger
Open Ingersoll Rand Inc.’s full ledger
A free account opens 5 company ledgers a month. All 24 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — Apr 29, 2026
Ingersoll Rand Q1 FY26 — Solid Start with Strong M&A Pipeline and Short-Cycle Improvement
Read the full callDec 2025 (Q4 FY25) — Feb 13, 2026
Ingersoll Rand Q4 FY25 — Strong Finish with Recurring Revenue Growth and Strategic M&A
Read the full callEvery analysed call
Ingersoll Rand earnings calls (IR)
Financials
What the filings say
Net profit, year on year: +323% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,861 | 1,899 | 1,717 | 1,888 | 1,955 | 2,091 | 1,847 | 2,049 |
| Operating profit | 356 | 379 | 303 | 76 | 376 | 390 | 290 | 380 |
| Operating margin | 19.1% | 19.9% | 17.6% | 4.0% | 19.2% | 18.7% | 15.7% | 18.6% |
| Interest | 64 | 62 | 61 | 63 | 65 | 65 | 64 | 63 |
| Profit before tax | 302 | 325 | 253 | 28 | 319 | 335 | 230 | 327 |
| Tax rate | 24.4% | 27.1% | 23.1% | 74.7% | 23.0% | 19.8% | 15.7% | 21.1% |
| Net profit | 222 | 230 | 187 | -115 | 244 | 266 | 192 | 257 |
| EPS ($ per share) | 0.55 | — | 0.46 | -0.29 | 0.62 | — | 0.49 | 0.66 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 2 | 2 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | -309 | -141 | -176 | 379 | 951 | 1,697 | 2,504 | 3,053 |
| Total liabilities | 2,811 | 2,759 | 6,869 | 6,083 | 5,509 | 5,717 | 7,765 | 8,143 |
| Fixed assets | 357 | 327 | 609 | 649 | 624 | 711 | 842 | 930 |
| Total assets | 4,487 | 4,628 | 16,059 | 15,155 | 14,766 | 15,564 | 18,010 | 18,297 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 445 | 343 | 914 | 628 | 865 | 1,377 | 1,397 | 1,356 |
| Cash from investing | -235 | -54 | -38 | — | — | -1,060 | -3,108 | -661 |
| Cash from financing | -373 | -11 | 329 | -1,157 | -954 | -337 | 1,708 | -1,054 |
| Net cash flow | -172 | 284 | 1,245 | 359 | -497 | -17 | -54 | -292 |
| Capital expenditure | -52 | -38 | -42 | -64 | -95 | -105 | -149 | -136 |
| Free cash flow | 392 | 305 | 872 | 564 | 771 | 1,272 | 1,248 | 1,220 |
IR revenue by segment
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Industrial Technologies and Services | 79% | 80% | 79% | 79% | 79% | 80% | 78% | 79% | +8.7% |
| Precision and Science Technologies | 21% | 20% | 21% | 21% | 21% | 20% | 22% | 21% | +7.7% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
IR operating KPIs by quarter
| KPI | Dec 2024 Q4 FY24 | Jun 2025 Q2 FY25 | Sep 2025 Q3 FY25 | Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|---|---|---|
| Book-to-bill ratio | 0.95 ratioBook-to-bill for the quarter was 0.95, finishing in line with our previous guidance of above 1x in the first half and below 1x in the second half.Source: earnings call transcript | 1.03 ratioOrders continued their strong start, up 8% year-over-year with a book-to-bill of 1.03x.Source: earnings call transcript | 0.99 ratioOrders showed continued strength in the third quarter, up 8% year-over-year or up 2% organically with a book-to-bill of 0.99x.Source: earnings call transcript | 0.93 ratioConsistent with normal seasonality, fourth quarter book-to-bill finished at 0.93x.Source: earnings call transcript | 1.07 ratioOrders finished up 5% year-over-year, resulting in a book-to-bill of 1.07x, which is consistent with normal seasonality.Source: earnings call transcript | 1 ratioBook-to-bill finished at 1.0 turns slightly lower than we typically see in the second quarter, primarily reflecting the delayed timing of several large project orders.Source: earnings call transcript | -6.5% |
| Book-to-bill ratio IT&S | — | 1.05 ratioBook-to-bill was 1.05x.Source: earnings call transcript | — | — | 1.08 ratioBook-to-bill for the quarter was 1.08x.Source: earnings call transcript | — | — |
| Book-to-bill ratio P&ST | — | 0.96 ratioQ2 orders in PST (sic) [ P&ST ] were up 13% year-over-year with a book-to-bill of 0.96x.Source: earnings call transcript | 1.01 ratioQ3 orders in PST were up 11% year-over-year with a book-to-bill of 1.01x.Source: earnings call transcript | 0.96 ratioQ4 orders in PST were up 6% year-over-year with a book-to-bill of 0.96x.Source: earnings call transcript | 1.04 ratioQ1 orders in PST were up 6% year-over-year with a book-to-bill of 1.04x.Source: earnings call transcript | — | +8.3% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Revenue by region
Q2 FY2026 · share of revenue
- Americas 48% ↓ 3 pt
- US 40% ↓ 4 pt
- EMEA 33% ↑ 1 pt
- Asia Pacific 19% ↑ 2 pt
- CN 12%
- Other Americas 8% ↑ 1 pt
- Other Asia Pacific 7%
As IR cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
130 filings between Dec 1, 2025 and Aug 20, 2026.
Open market
decisions to buy or sellPurchases
$1.00M
1 purchase by 1 insider
Sales
$59.54M
21 sales by 7 insiders
62% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 6
- Award — granted as compensation
- 59
- Option exercise — converted options into shares
- 43
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Reynal Vicente | — | $49.68M | Apr 13, 2026 |
| Kini Vikram | — | $2.74M | Feb 20, 2026 |
| Scheske Michael J | — | $1.99M | Feb 17, 2026 |
| Hepding Elizabeth Meloy | — | $1.77M | Feb 17, 2026 |
| Schiesl Andrew R | — | $1.76M | Feb 17, 2026 |
| Keene Kathleen M. | — | $1.19M | Feb 17, 2026 |
| Satpathy Aurobind | $1.00M | — | Aug 3, 2026 |
| Humphrey John | — | $412.4K | Feb 19, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Keene Kathleen M. See Remarks | Option exercise | 483 | — |
| Aug 20, 2026 | Kini Vikram Senior Vice President and CFO | Tax withheld | 390 | $30.9K |
| Aug 20, 2026 | Keene Kathleen M. See Remarks | Tax withheld | 156 | $12.4K |
| Aug 20, 2026 | Kini Vikram Senior Vice President and CFO | Option exercise | 898 | — |
| Aug 20, 2026 | Weatherred Michael A See Remarks | Option exercise | 967 | — |
| Aug 20, 2026 | Hepding Elizabeth Meloy See Remarks | Tax withheld | 189 | $15.0K |
| Aug 20, 2026 | Hepding Elizabeth Meloy See Remarks | Option exercise | 435 | — |
| Aug 20, 2026 | Weatherred Michael A See Remarks | Tax withheld | 429 | $34.0K |
| Aug 17, 2026 | Emmerich Matthew J See Remarks | Tax withheld | 345 | $28.4K |
| Aug 17, 2026 | Emmerich Matthew J See Remarks | Option exercise | 756 | — |
| Aug 6, 2026 | Weatherred Michael A See Remarks | Option exercise | 245 | — |
| Aug 6, 2026 | Schiesl Andrew R See Remarks | Tax withheld | 160 | $14.1K |
| Aug 6, 2026 | Schiesl Andrew R See Remarks | Option exercise | 367 | — |
| Aug 6, 2026 | Satpathy Aurobind Director | Option exercise | 1,258 | — |
| Aug 6, 2026 | Weatherred Michael A See Remarks | Tax withheld | 109 | $9.6K |
| Aug 6, 2026 | Swanenburg Michelle Director | Option exercise | 130 | — |
| Aug 3, 2026 | Satpathy Aurobind Director | Purchase | 11,538 | $1.00M |
| May 5, 2026 | Swanenburg Michelle Director | Option exercise | 1,876 | — |
| Apr 13, 2026 | Reynal Vicente See Remarks | Option exercise 10b5-1 plan | 30,492 | $323.5K |
| Apr 13, 2026 | Reynal Vicente See Remarks | Sale 10b5-1 plan | 30,492 | $2.68M |
| Mar 2, 2026 | Reynal Vicente See Remarks | Sale 10b5-1 plan | 118,044 | $11.11M |
| Mar 2, 2026 | Reynal Vicente See Remarks | Option exercise 10b5-1 plan | 118,044 | $1.25M |
| Feb 27, 2026 | Weatherred Michael A See Remarks | Option exercise | 761 | — |
| Feb 27, 2026 | Kini Vikram Senior Vice President and CFO | Option exercise | 1,348 | — |
| Feb 27, 2026 | Kini Vikram Senior Vice President and CFO | Tax withheld | 585 | $55.1K |
| Feb 27, 2026 | Hepding Elizabeth Meloy See Remarks | Option exercise | 405 | — |
| Feb 27, 2026 | Weatherred Michael A See Remarks | Tax withheld | 338 | $31.8K |
| Feb 27, 2026 | Hepding Elizabeth Meloy See Remarks | Tax withheld | 176 | $16.6K |
| Feb 27, 2026 | Emmerich Matthew J See Remarks | Tax withheld | 104 | $9.8K |
| Feb 27, 2026 | Emmerich Matthew J See Remarks | Option exercise | 287 | — |
| Feb 27, 2026 | Scheske Michael J VP, Chief Accounting Officer | Tax withheld | 195 | $18.4K |
| Feb 27, 2026 | Schiesl Andrew R See Remarks | Option exercise | 813 | — |
| Feb 27, 2026 | Keene Kathleen M. See Remarks | Tax withheld | 128 | $12.0K |
| Feb 27, 2026 | Schiesl Andrew R See Remarks | Tax withheld | 353 | $33.2K |
| Feb 27, 2026 | Reynal Vicente See Remarks | Tax withheld | 2,248 | $211.6K |
| Feb 27, 2026 | Reynal Vicente See Remarks | Option exercise | 5,186 | — |
| Feb 27, 2026 | Scheske Michael J VP, Chief Accounting Officer | Option exercise | 449 | — |
| Feb 27, 2026 | Keene Kathleen M. See Remarks | Option exercise | 449 | — |
| Feb 26, 2026 | Reynal Vicente See Remarks | Tax withheld | 3,412 | $322.5K |
| Feb 26, 2026 | Reynal Vicente See Remarks | Option exercise | 7,872 | — |
| Feb 26, 2026 | Sohovich JoAnna Director | Option exercise | 2,429 | — |
| Feb 26, 2026 | Stevenson Mark P Director | Option exercise | 2,309 | — |
| Feb 26, 2026 | Humphrey John Director | Option exercise | 2,609 | — |
| Feb 26, 2026 | Schiesl Andrew R See Remarks | Tax withheld | 407 | $38.5K |
| Feb 26, 2026 | Schiesl Andrew R See Remarks | Option exercise | 937 | — |
| Feb 26, 2026 | DONNELLY WILLIAM P Director | Option exercise | 3,029 | — |
| Feb 26, 2026 | Hartsock Jennifer Director | Option exercise | 2,429 | — |
| Feb 26, 2026 | Kini Vikram Senior Vice President and CFO | Tax withheld | 975 | $92.2K |
| Feb 26, 2026 | Kini Vikram Senior Vice President and CFO | Option exercise | 2,249 | — |
| Feb 26, 2026 | Weatherred Michael A See Remarks | Tax withheld | 665 | $62.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Ingersoll Rand Inc.
Free account. Everything above stays public.
Write why you follow Ingersoll Rand Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading